X4 Pharmaceuticals (XFOR)
3.29
-0.06 (1.79%)
Upcoming Events
Latest Headlines
X4 Pharmaceuticals targets 2028 data readout for neutropenia drug
October 29, 2026 4:31 PM - StreetInsider
X4 Pharmaceuticals Highlights Clinical Progress and Market Opportunity for Mavorixafor in Primary Chronic Neutropenia During Virtual Investor Day
October 29, 2026 4:30 PM - Globe NewsWire
Form 8-K X4 Pharmaceuticals, Inc For: Oct 29
October 29, 2026 10:00 AM - SEC Filing
Form 4 X4 Pharmaceuticals, Inc For: Oct 16 Filed by: Craig Adam R
October 19, 2026 4:06 PM - SEC Filing
X4 Pharmaceuticals to Host Virtual Investor Day on Thursday, October 29, 2026, Featuring Key Opinion Leaders
October 9, 2026 7:00 AM - Globe NewsWire
Form 8-K X4 Pharmaceuticals, Inc For: Oct 07
October 8, 2026 5:23 PM - SEC Filing
X4 Pharmaceuticals secures $150M debt facility with K2 HealthVentures
October 8, 2026 7:03 AM - StreetInsider
X4 Pharmaceuticals Secures Up to $150 Million Senior Debt Facility with K2 HealthVentures
October 8, 2026 7:00 AM - Globe NewsWire
Form SCHEDULE 13G/A X4 Pharmaceuticals, Inc Filed by: FMR LLC
October 7, 2026 11:47 AM - SEC Filing
Form 4 X4 Pharmaceuticals, Inc For: Oct 01 Filed by: KIRSKE DAVID
October 5, 2026 4:03 PM - SEC Filing
Form 144 X4 Pharmaceuticals, Inc Filed by: KIRSKE DAVID
October 1, 2026 8:06 PM - SEC Filing
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 1, 2026 4:30 PM - Globe NewsWire
Form SCHEDULE 13G X4 Pharmaceuticals, Inc Filed by: Venrock Healthcare Capital Partners III, L.P.
September 21, 2026 8:24 PM - SEC Filing
Form SCHEDULE 13G/A X4 Pharmaceuticals, Inc Filed by: PERCEPTIVE ADVISORS LLC
August 14, 2026 5:24 PM - SEC Filing
Form SCHEDULE 13G/A X4 Pharmaceuticals, Inc Filed by: Deep Track Capital, LP
August 14, 2026 8:35 AM - SEC Filing
Form 4 X4 Pharmaceuticals, Inc For: Aug 12 Filed by: Volpone John
August 13, 2026 4:14 PM - SEC Filing
Form 4 X4 Pharmaceuticals, Inc For: Aug 12 Filed by: Craig Adam R
August 13, 2026 4:12 PM - SEC Filing
Form 144 X4 Pharmaceuticals, Inc Filed by: Volpone John
August 13, 2026 4:00 PM - SEC Filing
Form 144 X4 Pharmaceuticals, Inc Filed by: Craig Adam R
August 13, 2026 4:00 PM - SEC Filing
X4 Pharmaceuticals (XFOR) Tops Q2 EPS by 6c
August 6, 2026 4:20 PM - StreetInsider
X4 Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 6, 2026 4:15 PM - Globe NewsWire
Form 10-Q X4 Pharmaceuticals, Inc For: Jun 30
August 6, 2026 4:13 PM - SEC Filing
Full Article List
